---
schema_version: "secwatch.filing_event.v1"
accession: "0000896622-26-000004"
form_type: "8-K"
ticker: "ATR"
cik: "0000896622"
company_name: "APTARGROUP, INC."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:44:10.669785+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aptar Q4 net income down 26%, adjusted EPS $1.25 vs $1.62; new $600M buyback

## Summary
- Reported sales +14% to $963M (core +5%); net income -26% to $74M ($1.13 EPS).
- Adjusted EPS $1.25 vs $1.62; adjusted EBITDA margin 19.8% vs 23.0%.
- Pharma core sales +4% (injectables +24%), Beauty +10%, Closures +1%.
- Board authorized new $600M share repurchase; Q1 2026 adjusted EPS guidance $1.13-$1.21.
- Returned $206M to shareholders in Q4 via buybacks and dividends; quarterly dividend $0.48.

## SEC filing metadata
- accession: 0000896622-26-000004
- form_type: 8-K
- ticker: ATR
- cik: 0000896622
- company_name: APTARGROUP, INC.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896622/000089662226000004/0000896622-26-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896622/000089662226000004/atr-20260205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896622-26-000004
- JSON: https://secwatch.observer/filing/0000896622-26-000004.json
- Plain text: https://secwatch.observer/filing/0000896622-26-000004.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.